Futures are down in early trading, with a jam-packed earnings and economy schedule on deck. April 25, 2024 | [Read Online]( Good Morning! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Letâs get ready to trade! Markets ð Stocks posted a mixed performance on Wednesday, but closed the session near where they began. The S&P 500 and Nasdaq extended their winning streak by the narrowest of margins. - Dow [-0.1%] - S&P 500 [<0.1%] - Nasdaq [+0.1%] - Russell 2K [-0.3%] Futures are down in early trading, with S&P 500 contracts showing a 0.6% ahead of the opening bell. What to Watch Today:
Todayâs schedule is jam-packed with notable corporate earnings and economy updates, so it could be a busy session. In the aftermarket, weâll hear from Microsoft, Google, and Intel. In a few minutes, weâll also get an update on Q1 GDP data, which could shed more light on the U.S. economyâs chances for a âsoft landingâ in the months ahead. [Elon Musk's "Project Dojo" is a Game-Changer]( Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation. [Click here for its name and ticker symbol.]( » Want an Ad-Free Experience + Top Growth Stock Picks? [Upgrade Now!]( Premarket Highlights ð â¡ï¸ Elon Musk's Promises Big, Can He Deliver? In the world of tech and stocks, Elon Musk remains a central figure. Recently, he refuted a Reuters report claiming Tesla was scrapping plans for a new, budget-friendly carâseen as crucial for the company's growth. Instead, he shifted focus and hyped up an upcoming "Tesla Robotaxi unveil" slated for August. This announcement alone was enough to push Tesla's stock up nearly 5% the following trading day. Tactical Shift ðÂ
The excitement continued into Tuesday evening when Tesla disclosed its quarterly results, revealing a strategic pivot. Instead of developing a completely new model, Tesla now plans to introduce a more affordable electric vehicle by adapting existing platforms. This move is a cost-effective strategy that could streamline production and leverage current technologies, satisfying investors amid growing concerns about Tesla's commitment to expanding its consumer base. Autonomous Ambitions ðÂ
However, the news wasn't all rosy. When it came to Teslaâs much-anticipated autonomous vehicle technologyâcritical for the future Robotaxisâthe update was underwhelming. Tesla offered little new information on its progress or methods to bolster investor confidence in its self-driving technology, sticking instead to previous assertions about having the right strategy. Despite this, Musk's pragmatic approach this time around helped the company's shares soar by 12%, a stark contrast to its recent sharp losses. Stock Surge ð¸Â
Even though Tesla's first-quarter financials were somewhat alarmingâwith cash burn exceeding expectations and the lowest quarterly cash flow since early 2020âthe market response was overwhelmingly positive. In fact, Wednesday's surge in Teslaâs market value was so significant it matched the entire market cap of General Motors. In summary, as markets ebb and flow, the drama surrounding Tesla's strategic decisions and Musk's vision of futuristic transport continues to captivate and occasionally reassure investors, proving once more that in the world of tech and stocks, there's never a dull moment. Featured Earnings ð°ï¸Â - Merck & Company [MRK] ... AM - Caterpillar [CAT] ... AM - Comcast [CMCSA] ... AM - Union Pacific [UNP] ... AM - S&P Global [SPGI] ... AM - Honeywell International [HON] ... AM - Microsoft [MSFT] ... PM - Alphabet Inc (Google) Class C [GOOG] ... PM - T-Mobile Us [TMUS] ... PM - Intel [INTC] ... PM Economy ð - GDP [Q1] ... 8:30a - Initial jobless claims [Apr] ... 8:30a - Advanced U.S. trade balance in goods [Mar] ... 8:30a - Advanced retail inventories [Mar] ... 8:30a - Advanced wholesale inventories [Mar] ... 8:30a - Pending home sales [Mar] ... 10:00a Running Hot ð¥ Gainers - Barfresh Food [BRFH] >> +108.1% - Intelligent Living [ILAG] >> +53.7% - Ultralife [ULBI] >> +17.8% Decliners - Scholar Rock [SRRK] >> (29.0%) - Chicken Soup [CSSE] >> (17.8%) - Biophytis [BPTS] >> (17.8%) ReAlpha Corp [AIRE] - Last Close: $1.16 Yesterday, ReAlpha announced the launch of real estateâs first AI-powered, zero-commission smart buyerâs agent: Claire. Share of AIRE rallied to a 9.20% gain on Wednesday following the announcement, but the breakout didnât end at the closing bell. AIRE is up another 44.8% in todayâs premarket, on more than 2.5 million shares traded. My Take: AIRE is getting a big boost from this news, but itâs likely to pullback before itâs all said and done. If youâre already in this one, donât hesitate to take profits if it starts to go the wrong way. Processa Pharma [PCSA] - Last Close: $1.62 This morning, analysts at HC Wainwright initiated coverage on Processa Pharma with a âbuyâ rating and an $8 price target. The analystâs target represents a 393% premium compared to PCSAâs Wednesday closing price. PCSA is up 17.2% on over 5 million shares traded. My Take: This rally seems like itâs a tad overdone, but PCSA was trading for more than $15 a share in December, so the $8 price target is achievable if the stock can pivot into a more favorable trend. . Optinose [OPTN] - Last Close: $0.9253 Optinose is on the move after providing an early-morning corporate update on a crucial product launch and its preliminary Q1 financial performance. The FDA recently approved a new indication for its XHANCE nasal spray, and Optinose provided several updates on its plan for the product. The company said preliminary Q1 net revenue from its XHANCE product is $14.9 million, marking a YoY increase of 26%. Optinose also said it expects to post positive income from operations in 2024. OPTN is up 21.0% on over 350K shares traded. My Take: Sounds like OPTN has a winner on its hands with XHANCE, but you wouldnât know it by looking at its recent chart. Maybe this announcement will help it get back on track. Nuwellis [NUWE] - Last Close: $0.2521 Nuwellis is running hot after it won a crucial patent titled "Venous Blood Flow Stimulator For Extracorporeal Therapy" on Monday. The medical device company rallied in response to the announcement, but shares pulled back over the next couple of days. However, the pullback appears to have been overdone because shares are rebounding today. NUWE is up 19.0% on over 2.5 million shares traded. My Take: NUWE has been downtrending since at least late October, but the move may be bottoming out. The stock has experienced a significant spike in trading volume since its Monday announcement. That's it for today! Thanks for reading, and good luck out there! Best Regards, â Chris D.
Elite Trade Club Text ELITE to 47121 or [click here](Â to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( [Privacy Policy]( | [Advertiser Disclosure]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247
Orlando, Florida 32828, United States of America [[beehiiv logo]Powered by beehiiv](